Gujarat Terce Laboratories Ltd

Gujarat Terce Laboratories Ltd | Sector: Pharmaceuticals | ISIN: INE499G01013

Trade

Corporate Actions

07 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2023

12:00 AM

Results

View Details

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Nov , 2022

12:00 AM

Results

View Details

31 May , 2022

12:00 AM

AGM

Announcement date: 31 May , 2022

View Details

27 Jul , 2022

12:00 AM

Results

View Details

27 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 May , 2022

12:00 AM

Results

View Details

31 May , 2022

12:00 AM

BookCloser

View Details

Gujarat Terce Laboratories Ltd News and Update

Adani Power sells Support Properties Private Ltd to AdaniConnex

24 March, 2023 |
4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Power Grid Corporation acquires Khavda II-C Transmission Ltd

23 March, 2023 |
4:02 PM

HPCL to build third LPG underground storage facility, in Gujarat

23 March, 2023 |
4:02 PM

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
23 March, 2023 |
4:02 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	972.80	89.99	2,33,407.31	486.73	1.03	4,549.90	108.48
Divis Laboratories Ltd	2,809.00	31.40	74,497.12	310.90	1.07	1,689.83	454.85
Dr Reddys Laboratories Ltd	4,462.75	31.49	74,309.82	324.60	0.67	3,879.60	1,156.21
Cipla Ltd	877.00	25.58	70,787.11	678.52	0.57	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,517.75	48.99	51,379.40	229.00	1.58	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Gujarat Terce Laboratories Ltd

Amrutbhai P Prajapati
Whole-time Director

Chhayaben Ashwinbhai Shah
Independent Director

Viplav Suryakantbhai Khamar
Independent Director

Aalap Prajapati
Managing Director & CEO

Surendra Kumar Sharma
Independent Director

Navinchandra Patel
Independent Director

Natwarbhai P Prajapati
Chairman & Wholetime Director

Summary

Summary Info Not Found

Reports by Gujarat Terce Laboratories Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Gujarat Terce Laboratories Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Gujarat Terce Laboratories Ltd

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 26 March , 2023 | 02:01 PM

Knowledge Center

Gujarat Terce Laboratories Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Gujarat Terce Laboratories Ltd

Amrutbhai P Prajapati

Chhayaben Ashwinbhai Shah

Viplav Suryakantbhai Khamar

Aalap Prajapati

Surendra Kumar Sharma

Navinchandra Patel

Natwarbhai P Prajapati

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
26 March , 2023 | 02:01 PM